Description: Unnecessary Expense : An Antidote for the Billion Dollar Drug Problem, Hardcover by Theuer, Charles; Adams, Bonne (CON); Wiggins, Mark (CON); Brown, Scott (CON), ISBN 1950863573, ISBN-13 9781950863570, Brand New, Free shipping in the US The drug development process in the United States has become so weighted down by a business-as-usual paradigm that an average of more than $2 billion is spent to secure FDA approval for every new drug. Because the investment required is so extreme, drug development companies are understandably focused on discovering and developing drugs designed for large patient populations: diseases experienced by millions, such as high blood pressure, diabetes, or some of the more common cancers. In Unnecessary Expense, Dr. Charles Theuer, CEO of TRACON Pharmaceuticals, outlines the problem and offers a solution: an aligned and streamlined model that emphasizes quality and reduces the time and cost of drug development, while also harnessing global innovation to benefit patients with rare diseases in urgent need of new treatments. Here Dr. Theuer shows the value of a pharmaceutical paradigm shift, to enable the development of drugs for patients who need them, at a fraction of the time and cost.
Price: 28.3 USD
Location: Jessup, Maryland
End Time: 2024-03-18T20:11:06.000Z
Shipping Cost: 0 USD
Product Images
Item Specifics
Return shipping will be paid by: Buyer
All returns accepted: Returns Accepted
Item must be returned within: 14 Days
Refund will be given as: Money Back
Return policy details:
Book Title: Unnecessary Expense : An Antidote for the Billion Dollar Drug Pro
Item Length: 9.1in
Item Height: 0.9in
Item Width: 6in
Author: Scott Brown, Charles Theuer, Bonne Adams, Mark Wiggins
Publication Name: Unnecessary Expense : an Antidote for the Billion Dollar Drug Problem
Format: Hardcover
Language: English
Publisher: Forbes Books
Publication Year: 2021
Type: Textbook
Number of Pages: 192 Pages
